{"id":"NCT03663205","sponsor":"BeiGene","briefTitle":"A Study Evaluating the Efficacy and Safety of Tislelizumab Versus Chemotherapy in Advanced Non-Squamous Non-small Cell Lung Cancer","officialTitle":"A Phase 3, Open-Label, Multicenter, Randomized Study to Investigate the Efficacy and Safety of Tislelizumab (BGB-A317) (Anti-PD1 Antibody) Combined With Platinum-Pemetrexed Versus Platinum-Pemetrexed Alone as First-line Treatment for Patients With Stage IIIB or IV Non-Squamous Non-Small Cell Lung Cancer","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2018-07-23","primaryCompletion":"2020-01-23","completion":"2023-04-26","firstPosted":"2018-09-10","resultsPosted":"2024-11-25","lastUpdate":"2025-02-04"},"enrollment":334,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Non-Small Cell Lung Cancer"],"interventions":[{"type":"DRUG","name":"Tislelizumab","otherNames":["Tevimbra","BGB-A317"]},{"type":"DRUG","name":"Cisplatin","otherNames":[]},{"type":"DRUG","name":"Carboplatin","otherNames":[]},{"type":"DRUG","name":"Pemetrexed","otherNames":[]}],"arms":[{"label":"Tislelizumab + Platinum + Pemetrexed","type":"EXPERIMENTAL"},{"label":"Platinum + Pemetrexed","type":"ACTIVE_COMPARATOR"}],"summary":"This study evaluated the efficacy and safety of tislelizumab in combination with platinum (cisplatin or carboplatin) and pemetrexed compared with platinum and pemetrexed alone as first-line treatment in participants with Stage IIIB or IV non-squamous non-small cell lung cancer (NSCLC).","primaryOutcome":{"measure":"Progression Free Survival (PFS) Assessed by Independent Review Committee (IRC) Assessment","timeFrame":"Through primary analysis data cut-off date of 23JAN2020 (up to approximately 1 year and 6 months)","effectByArm":[{"arm":"Tislelizumab + Platinum + Pemetrexed","deltaMin":9.7,"sd":null},{"arm":"Platinum + Pemetrexed","deltaMin":7.6,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"0.0054"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":47,"countries":["China"]},"refs":{"pmids":["34033975","35333492"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":99,"n":222},"commonTop":["Anaemia","White blood cell count decreased","Neutrophil count decreased","Alanine aminotransferase increased","Platelet count decreased"]}}